Our previous data showed a critical role of a lipid kinase sphingosine kinase 1 (SK1) in prostate cancer chemoresistance, and introduced the concept of SK1 as a “sensor” to anticancer therapies [20]. The gene discussed is SPHK1; the disease is Familial prostate cancer.